Showing results (661-670 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Outcomes-Based Contracting Experience: Research Findings from U.S. and European StakeholdersTara Nazareth, John J Ko, Rahul Sasane, et al.Journal of Managed Care & Specialty Pharmacy|June 28, 2016
What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?Anna Hung, Eleanor M PerfettoJournal of Managed Care & Specialty Pharmacy|June 28, 2016
Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating SystemVibha Desai, David Nau, Mark Conklin, et al.Journal of Managed Care & Specialty Pharmacy|June 28, 2016
Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?Jamie T Ta, Sara C Erickson, Wenyi Amanda Qiu, et al.Journal of Managed Care & Specialty Pharmacy|June 28, 2016
Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care SettingBenjamin Chastek, Stephanie Korrer, Saurabh P Nagar, et al.Journal of Managed Care & Specialty Pharmacy|June 28, 2016
Does Hepatitis C Treatment Adherence Affect Risk of Liver Transplantation? A Historical Cohort StudyDerek Ems, Patrick Racsa, Chris Anderson, et al.Journal of Managed Care & Specialty Pharmacy|September 4, 2020
Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective AnalysisQing Huang, Sujana Borra, Jieni Li, et al.Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohortAnuja Roy, Andrew Peterson, Nick Marchant, et al.Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United StatesTsung-Ying Lee, Julia F Slejko, Bernard Bright Davies-Teye, et al.Journal of Managed Care & Specialty Pharmacy|June 23, 2022
When are breakthrough therapies cost-effective?Natalia Olchanski, Pei-Jung Lin, Wei-Shi Yeh, et al.Pageof 185